NCT01953822View on ClinicalTrials.gov

Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom

CompletedOBSERVATIONAL
Enrollment

1,053

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Infections, Papillomavirus
Interventions
OTHER

Data collection

Data collection from an existing electronic healthcare databases - Clinical Practice Research Datalink (CPRD) GOLD.

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01953822 - Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom | Biotech Hunter | Biotech Hunter